September is designated as Prostate Cancer Awareness Month, with various global activities that highlight and increase awareness of prostate cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of prostate cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches”
by Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik and Viktor Grünwald
Cancers 2023, 15(2), 461; https://doi.org/10.3390/cancers15020461
Available online: https://www.mdpi.com/2072-6694/15/2/461

“Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0”
by Georges Gebrael, Kamal Kant Sahu, Beverly Chigarira, Nishita Tripathi, Vinay Mathew Thomas, Nicolas Sayegh, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami and Haoran Li
Cancers 2023, 15(14), 3717; https://doi.org/10.3390/cancers15143717
Available online: https://www.mdpi.com/2072-6694/15/14/3717

“Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer”
by Giovanni Tossetta, Sonia Fantone, Daniela Marzioni and Roberta Mazzucchelli
Cancers 2023, 15(11), 3037; https://doi.org/10.3390/cancers15113037
Available online: https://www.mdpi.com/2072-6694/15/11/3037

“Thin-Slice Prostate MRI Enabled by Deep Learning Image Reconstruction”
by Sebastian Gassenmaier, Verena Warm, Dominik Nickel, Elisabeth Weiland, Judith Herrmann, Haidara Almansour, Daniel Wessling and Saif Afat
Cancers 2023, 15(3), 578; https://doi.org/10.3390/cancers15030578
Available online: https://www.mdpi.com/2072-6694/15/3/578

“The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome”
by Kazutoshi Fujita, Makoto Matsushita, Marco A. De Velasco, Koji Hatano, Takafumi Minami, Norio Nonomura and Hirotsugu Uemura
Cancers 2023, 15(5), 1375; https://doi.org/10.3390/cancers15051375
Available online: https://www.mdpi.com/2072-6694/15/5/1375

“Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer”
by Diana C. Simão, Kevin K. Zarrabi, José L. Mendes, Ricardo Luz, Jorge A. Garcia, William K. Kelly and Pedro C. Barata
Cancers 2023, 15(5), 1412; https://doi.org/10.3390/cancers15051412
Available online: https://www.mdpi.com/2072-6694/15/5/1412

“Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with ⁶⁸Ga-PSMA PET/CT Features in Primary Staging”
by Luigia Vetrone, Riccardo Mei, Lorenzo Bianchi, Francesca Giunchi, Andrea Farolfi, Paolo Castellucci, Matteo Droghetti, Massimiliano Presutti, Alessio Degiovanni, Riccardo Schiavina et al.
Cancers 2023, 15(6), 1716; https://doi.org/10.3390/cancers15061716
Available online: https://www.mdpi.com/2072-6694/15/6/1716

“Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects”
by Ahmad Chaddad, Guina Tan, Xiaojuan Liang, Lama Hassan, Saima Rathore, Christian Desrosiers, Yousef Katib and Tamim Niazi
Cancers 2023, 15(15), 3839; https://doi.org/10.3390/cancers15153839
Available online: https://www.mdpi.com/2072-6694/15/15/3839

“Detection Efficacy of ⁶⁸Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience”
by Caroline Burgard, Manuela A. Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J. Marlowe, Mathias Schreckenberger, Samer Ezziddin and Florian Rosar
Cancers 2023, 15(5), 1376; https://doi.org/10.3390/cancers15051376
Available online: https://www.mdpi.com/2072-6694/15/5/1376

“Advances in PARP Inhibitors for Prostate Cancer”
by Steven Tisseverasinghe, Boris Bahoric, Maurice Anidjar, Stephan Probst and Tamim Niazi
Cancers 2023, 15(6), 1849; https://doi.org/10.3390/cancers15061849
Available online: https://www.mdpi.com/2072-6694/15/6/1849

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office